Ligand Pharmaceuticals, Inc. (LGND)

181.54 -4.04 (-2.18%) USD  |  NASDAQ  |  Feb 12, 11:28
More

Ligand Pharmaceuticals Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Johnson & Johnson Upgrade
Elanco Animal Health, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Krystal Biotech, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade